Tech Company Financing Transactions
MedCPU Funding Round
On 2/29/2016, MedCPU landed $35 million in Series E financing from UPMC Health Plan and Merck Global Health Innovation Fund.
Transaction Overview
Company Name
Announced On
2/29/2016
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series E
Investors
UPMC Health Plan (Lead Investor) (Tal Heppenstall)
Merck Global Health Innovation Fund (Joel Krikston)
Proceeds Purpose
Our partnership with medCPU will provide UPMC with technology and solutions that will be immediately valuable to our clinicians and patients. Longer term, this powerful technology will enable the development of other data-dependent applications in such critical areas as care management, population health and consumer engagement.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
2100 Wharton St. 503
Pittsburgh, PA 15203
USA
Pittsburgh, PA 15203
USA
Phone
Website
Email Address
Overview
MedCPU was created by physicians with over 17 years experience in introducing clinical decision support technologies into the high acuity clinical settings. We understand the pressures of today's healthcare environment, and the deficiencies of healthcare IT that may increase the challenges clinicians are facing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eyal Ephrat
Chief Financial Officer
Andrew Levitch
Chief Medical Officer
Itay Klaz
President
Sonia Ben-Yehuda
VP - Operations
Steve Oden
VP - Product Management
Noam Velan
Browse more venture capital transactions:
Prev: 2/29/2016: Alzheon venture capital transaction
Next: 2/29/2016: Terbium Labs venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs